The Cellular Immunotherapy Revolution: Arming the Immune System for Precision Therapy

作者: Richard D. Paucek , David Baltimore , Guideng Li

DOI: 10.1016/J.IT.2019.02.002

关键词: Precision medicineImmune systemChimeric antigen receptorCytotoxic T cellPersonalized medicineT cellBioinformaticsRepurposingImmunotherapyMedicineImmunologyImmunology and Allergy

摘要: Immunotherapy treatments harnessing the patient's immune system herald a new era of personalized medicine, offering hope for curative responses in patients with serious illnesses. Cell-mediated immunity can eliminate cancer cells and provide durable remissions. This often relies on repurposing cytotoxic T cell activity through modified receptors or chimeric antigen receptors. Furthermore, synthetic biology has expanded engineering toolkit to more functionality, including disease targeting, potency, safety. We focus cell-based immunotherapy, highlighting discoveries genetic therapeutic use. also examine emerging paths that could be undertaken improve this novel class drugs, discuss challenges toxicities as well other limitations cellular immunotherapy.

参考文章(113)
Wong Yu, Ning Jiang, Peter J.R. Ebert, Brian A. Kidd, Sabina Müller, Peder J. Lund, Jeremy Juang, Keishi Adachi, Tiffany Tse, Michael E. Birnbaum, Evan W. Newell, Darrell M. Wilson, Gijsbert M. Grotenbreg, Salvatore Valitutti, Stephen R. Quake, Mark M. Davis, Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8+ T Lymphocytes Immunity. ,vol. 42, pp. 929- 941 ,(2015) , 10.1016/J.IMMUNI.2015.05.001
Shannon L. Maude, David T. Teachey, David L. Porter, Stephan A. Grupp, CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia Blood. ,vol. 125, pp. 4017- 4023 ,(2015) , 10.1182/BLOOD-2014-12-580068
C.-Y. Wu, K. T. Roybal, E. M. Puchner, J. Onuffer, W. A. Lim, Remote control of therapeutic T cells through a small molecule-gated chimeric receptor Science. ,vol. 350, pp. 4077- ,(2015) , 10.1126/SCIENCE.AAB4077
Aaron P Rapoport, Edward A Stadtmauer, Gwendolyn K Binder-Scholl, Olga Goloubeva, Dan T Vogl, Simon F Lacey, Ashraf Z Badros, Alfred Garfall, Brendan Weiss, Jeffrey Finklestein, Irina Kulikovskaya, Sanjoy K Sinha, Shari Kronsberg, Minnal Gupta, Sarah Bond, Luca Melchiori, Joanna E Brewer, Alan D Bennett, Andrew B Gerry, Nicholas J Pumphrey, Daniel Williams, Helen K Tayton- Martin, Lilliam Ribeiro, Tom Holdich, Saul Yanovich, Nancy Hardy, Jean Yared, Naseem Kerr, Sunita Philip, Sandra Westphal, Don L Siegel, Bruce L Levine, Bent K Jakobsen, Michael Kalos, Carl H June, NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma Nature Medicine. ,vol. 21, pp. 914- 921 ,(2015) , 10.1038/NM.3910
Adrian G Murphy, Lei Zheng, Small molecule drugs with immunomodulatory effects in cancer Human Vaccines & Immunotherapeutics. ,vol. 11, pp. 2463- 2468 ,(2015) , 10.1080/21645515.2015.1057363
Ryan J. Martinez, Brian D. Evavold, Lower Affinity T Cells are Critical Components and Active Participants of the Immune Response. Frontiers in Immunology. ,vol. 6, pp. 468- 468 ,(2015) , 10.3389/FIMMU.2015.00468
Feriyl Bhaijee, Thomas Huebner, Ralph H. Hruban, Laura D. Wood, Nathan Cuka, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, Shibin Zhou, Toby C. Cornish, Janis M. Taube, Robert A. Anders, James R. Eshleman, Bert Vogelstein, Luis A. Diaz, Dung T. Le, Jennifer N. Uram, Hao Wang, Bjarne R. Bartlett, Holly Kemberling, Aleksandra D. Eyring, Andrew D. Skora, Brandon S. Luber, Nilofer S. Azad, Dan Laheru, Barbara Biedrzycki, Ross C. Donehower, Atif Zaheer, George A. Fisher, Todd S. Crocenzi, James J. Lee, Steven M. Duffy, Richard M. Goldberg, Albert de la Chapelle, Minori Koshiji, PD-1 Blockade in Tumors with Mismatch-Repair Deficiency The New England Journal of Medicine. ,vol. 372, pp. 2509- 2520 ,(2015) , 10.1056/NEJMOA1500596
Nachimuthu Chinnasamy, Jennifer A. Wargo, Zhiya Yu, Mahadev Rao, Timothy L. Frankel, John P. Riley, Jenny J. Hong, Maria R. Parkhurst, Steven A. Feldman, David S. Schrump, Nicholas P. Restifo, Paul F. Robbins, Steven A. Rosenberg, Richard A. Morgan, A TCR Targeting the HLA-A*0201–Restricted Epitope of MAGE-A3 Recognizes Multiple Epitopes of the MAGE-A Antigen Superfamily in Several Types of Cancer Journal of Immunology. ,vol. 186, pp. 685- 696 ,(2011) , 10.4049/JIMMUNOL.1001775
Mark E. Dudley, Colin A. Gross, Robert P.T. Somerville, Young Hong, Nicholas P. Schaub, Shannon F. Rosati, Donald E. White, Debbie Nathan, Nicholas P. Restifo, Seth M. Steinberg, John R. Wunderlich, Udai S. Kammula, Richard M. Sherry, James C. Yang, Giao Q. Phan, Marybeth S. Hughes, Carolyn M. Laurencot, Steven A. Rosenberg, Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma Journal of Clinical Oncology. ,vol. 31, pp. 2152- 2159 ,(2013) , 10.1200/JCO.2012.46.6441
B. M. Carreno, V. Magrini, M. Becker-Hapak, S. Kaabinejadian, J. Hundal, A. A. Petti, A. Ly, W.-R. Lie, W. H. Hildebrand, E. R. Mardis, G. P. Linette, A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells Science. ,vol. 348, pp. 803- 808 ,(2015) , 10.1126/SCIENCE.AAA3828